Physician visits prior to treatment for clinically localized prostate cancer.

scientific article

Physician visits prior to treatment for clinically localized prostate cancer. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHINTERNMED.2010.1
P932PMC publication ID4251764
P698PubMed publication ID20212180
P5875ResearchGate publication ID41825559

P50authorPeter BachQ7172626
Michael J ZelefskyQ51936867
Elena B ElkinQ115151505
P2093author name stringPeter T Scardino
Colin B Begg
Deborah Schrag
Justin E Bekelman
Ethan M Basch
Thomas L Jang
Yihai Liu
P2860cites workCancer statistics, 2009Q29547625
Development of a comorbidity index using physician claims dataQ30623996
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurementQ30714854
Radical prostatectomy versus watchful waiting in early prostate cancerQ34418166
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancerQ36433781
Assessing quality using administrative dataQ36893036
The Effect of Clustering of Outcomes on the Association of Procedure Volume and Surgical OutcomesQ47433316
Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologistsQ47801816
Potential for cancer related health services research using a linked Medicare-tumor registry database.Q50125205
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.Q55067996
How expert physicians would wish to be treated if they had genitourinary cancerQ58876886
Accuracy of diagnostic coding for Medicare patients under the prospective-payment systemQ70374986
Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancerQ73924100
Variations in morbidity after radical prostatectomyQ77924924
United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by regionQ78390337
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P304page(s)440-450
P577publication date2010-03-01
P1433published inJAMA Internal MedicineQ177428
P1476titlePhysician visits prior to treatment for clinically localized prostate cancer
P478volume170

Reverse relations

cites work (P2860)
Q57128167Q57128167
Q28652628A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer
Q91328899Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation
Q39591491Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan
Q87587279Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer'
Q87992507Comparative Analysis of the Views of Oncologic Subspecialists and Palliative/Supportive Care Physicians Regarding Advanced Care Planning and End-of-Life Care
Q91725984Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer
Q51248430Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
Q35577609Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis
Q46259067Decision-making processes among men with low-risk prostate cancer: A survey study
Q57835104Dental care providers' decision making regarding maintenance of compromised teeth and implant therapy indication: an analysis of gender and enrollment in teaching positions
Q36823071Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program
Q87019072Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey
Q35114920Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population
Q95503798Editorial comment
Q90557517Empowering patients in decision-making in radiation oncology - can we do better?
Q34335177Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience.
Q36522791Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer
Q89496416Exposure to radiation and medical oncology training: A survey of Canadian urology residents and fellows
Q42669921Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Q55312114Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database.
Q93349353Factors underlying treatment decision-making for localized prostate cancer in the U.S. and Canada: A scoping review using principal component analysis
Q64066683Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence
Q35602510Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse
Q36776998Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications
Q35869811High-risk prostate cancer-classification and therapy
Q30417174Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications
Q34679220Impact of age at diagnosis on prostate cancer treatment and survival
Q36520523Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions
Q49987316Incongruence in treatment decision making is associated with lower health-related quality of life among prostate cancer survivors: results from the PiCTure study
Q39400229Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study
Q41141658Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer
Q36222876Influence of primary care on breast cancer outcomes among Medicare beneficiaries
Q41814411Information needs of early-stage prostate cancer patients: within- and between-group agreement of patients and health professionals
Q41737229Interdisciplinary counseling service for renal malignancies: a patient-centered approach to raise guideline adherence
Q35459197Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive?
Q45538851Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-up
Q40732738Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer
Q24235544Low-dose rate brachytherapy for men with localized prostate cancer
Q41645248Multidisciplinary Oncology Education: Going Beyond Tumor Board.
Q47179230Out of the Basement and Into the Classroom: Pathways for Expanding the Role of Radiation Oncologists in Medical Student Education.
Q34696349Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer
Q57169399Overdiagnosis in primary care: framing the problem and finding solutions
Q46627682Patient Decision Making Prior to Radical Prostatectomy: What Is and Is Not Involved
Q85225385Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions
Q84467389Patients and solipsism: the psychology of decision making for prostate cancer treatment
Q36905270Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer
Q39023568Perineal discomfort in prostatic adenocarcinoma
Q88560388Physician visits and the timing of skeletal-related events among men newly diagnosed with metastatic prostate cancer: A cohort analysis
Q44898794Population-based comparative effectiveness of salvage radical prostatectomy vs cryotherapy
Q43978055Preferences of dental care providers in maintaining compromised teeth in relation to their professional status: implants instead of periodontally involved maxillary molars?
Q39776492Prostate Cancer Care Before and After Medicare Eligibility.
Q85421133Prostate cancer: challenges in selecting the optimal therapy
Q31138079Provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care
Q35819651Racial disparities in changing to a high-volume urologist among men with localized prostate cancer
Q38432682Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes
Q35743202Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer
Q48194820Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer
Q36534788Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer
Q36520534Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer
Q88548478Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space
Q35705334Shared decision making in oncology practice: what do oncologists need to know?
Q38775761Specialist visits and initiation of cancer-directed treatment among a large cohort of men diagnosed with prostate cancer.
Q48085035Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer
Q55215370Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis.
Q33946732Surgical quality is more than volume: the association between changing urologists and complications for patients with localized prostate cancer
Q50958640The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
Q39620429The Association Between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-risk Prostate Cancer.
Q47900716The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.
Q53277349The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation.
Q38414986The impact of county-level radiation oncologist density on prostate cancer mortality in the United States
Q36290824The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience
Q42265374Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer
Q48250064Trust versus paternalism
Q53168767Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.
Q38019954Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC).
Q92100760Validation of an Algorithm for Claims-based Incidence of Prostate Cancer
Q40967147Variation in prostate cancer treatment associated with population density of the county of residence
Q87187663Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty
Q40209684When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment
Q38366517Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer.
Q53199712[Decision aids for patients are widely accepted by German urologists : A survey among members of the German Society of Urology (DGU) and the Federation of German Urologists (BDU)].

Search more.